GLUE vs VNO · rev $13.2M vs rev $921.3M
Monte Rosa Therapeutics Inc (GLUE) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Monte Rosa Therapeutics Inc (GLUE) is a biotechnology company listed on NASDAQ.
VNO (VNO) common stock.
Latest reported GLUE revenue for 2026-06-30 was $13.2M. Net income was -$87.9M. GLUE currently screens at market cap $1.56B.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
GLUE currently screens at market cap $1.56B. VNO currently screens at market cap $0.
Not investment advice. Open the GLUE and VNO stock pages for the full models.
Not investment advice.